Skip to content

Effect of Dexmedomidine in pediatric anesthesia

The effect of low dose Dexmedetomidine in reducing the dose of analgesic and sedative medications in the pediatric intensive care unit

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230520058235N1
Enrollment
60
Registered
2023-07-23
Start date
2023-08-23
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opioid related disorders in pediatric intensive care unit. Opioid related disorders

Interventions

Intervention 1: Intervention group:In this group, patients will be anesthetized with 0.1 milligram per kilogram of intravenous Midazolam and 1 (or more) micrograms per kilogram of Fentanyl along with

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 12 Years

Inclusion criteria

Inclusion criteria: Age 1 year to 12 years Admission to pediatric intensive care unit (PICU) Under mechanical ventilation and sedation

Exclusion criteria

Exclusion criteria: Children receiving Barbiturates Persistent bradycardia (less than 5th percentile of normal for age) Hypotension (less than 5th percentile of normal age) Cardiac arrhythmia Involvement of the central nervous system (brain trauma, encephalitis, meningitis...)

Design outcomes

Primary

MeasureTime frame
Determining and comparing the needed total Fentanyl dose in each group. Timepoint: From enrollment up to seven days. Method of measurement: Dose counting.;Determining and comparing the needed total Midazolam dose in each group. Timepoint: From enrollment up to seven days. Method of measurement: Dose counting.

Secondary

MeasureTime frame
Determining the need for a second sedative drug in each group. Timepoint: From enrollment up to seven days. Method of measurement: Patient file.;Determining the need for the third sedative drug in each group. Timepoint: From enrollment up to seven days. Method of measurement: Patient file.;Determining the need for the muscle relaxant in each group. Timepoint: From enrollment up to seven days. Method of measurement: Patient file.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNajmeh Forouzan

Shahid Beheshti University of Medical Sciences

najmeh.star@ymail.com+98 21 2222 7020

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026